Novo Nordisk AS Newswire

Novo Nordisk AS Newswire

Comprehensive Real-Time News Feed for Novo Nordisk AS.

Results 1 - 20 of 698 in Novo Nordisk AS

  1. Novo Nordisk A/S (NVO) Holdings Increased by MUFG Americas Holdings CorpRead the original story w/Photo

    4 hrs ago | Daily Political

    MUFG Americas Holdings Corp grew its holdings in Novo Nordisk A/S by 673.5% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 11,603 shares of the company's stock after purchasing an additional 10,103 shares during the period.

    Comment?

  2. Human Growth Hormone (HGH) Market: Drivers, Restraints, Opportunities, and Threats 2018-2028Read the original story

    Yesterday | SBWire

    Human Growth Hormone Market : Overview Human growth hormone, also known as somatotropin or growth hormone, helps in the growth of all the essential tissues of the body including bones. It is one of the most essential hormones required by a human body.

    Comment?

  3. 6 Stocks With Margin of Safety and Growing Book ValueRead the original story w/Photo

    Friday | GuruFocus.com

    According to the GuruFocus All-In-One Screener , the following companies have grown their book value per share over the last decade. BV/S is calculated as total equity minus preferred stock, divided by shares outstanding.

    Comment?

  4. Analysts Offer Predictions for Novo Nordisk A/S's FY2018 EarningsRead the original story w/Photo

    Thursday Dec 13 | AmericanBankingNews.com

    Jefferies Financial Group issued their FY2018 earnings per share estimates for shares of Novo Nordisk A/S in a research note issued on Tuesday, December 11th. Jefferies Financial Group analyst P. Welford anticipates that the company will post earnings of $2.42 per share for the year.

    Comment?

  5. Hikari Tsushin Inc. Reduces Holdings in Novo Nordisk A/SRead the original story w/Photo

    Wednesday Dec 12 | AmericanBankingNews.com

    Hikari Tsushin Inc. lessened its stake in Novo Nordisk A/S by 14.5% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 118,280 shares of the company's stock after selling 20,000 shares during the quarter.

    Comment?

  6. Novo Nordisk Purchases Berkeley Lights Beacon PlatformRead the original story w/Photo

    Wednesday Dec 12 | Contract Pharma Breaking News

    Novo Nordisk has purchased Berkeley Lights Beacon Optofluidic platform to accelerate workflows in cell line development and to use the platform for future protein and antibody discovery. The Beacon platform aims to reduce the extensive resources typically required to generate a cell line for commercial production by allowing for parallel screening, maintenance and analysis of thousands of cells.

    Comment?

  7. Novo Nordisk not engaged in economic activity in Nagorno-Karabakh regionRead the original story w/Photo

    Wednesday Dec 12 | Today.Az

    The Danish company Novo Nordisk is not engaged in any economic activity in the Nagorno-Karabakh region, Trend reports citing the Azerbaijani Foreign Ministry on Dec. 11. According to the instructions of the Azerbaijani Foreign Ministry, the country's embassy in the UK investigated the information about the sale of medicines by Novo Nordisk to the separatist regime created in the occupied Azerbaijani territories. As a result of the investigation, it was revealed that Novo Nordisk is not engaged in any economic activity in the Nagorno-Karabakh region.

    Comment?

  8. Deutsche Bank Reiterates "Buy" Rating for Novo Nordisk A/SRead the original story w/Photo

    Monday Dec 10 | AmericanBankingNews.com

    NVO has been the topic of a number of other reports. Zacks Investment Research downgraded Novo Nordisk A/S from a "buy" rating to a "sell" rating in a report on Wednesday, October 10th.

    Comment?

  9. Novo Nordisk opens one-stop Diabetes Support Centre in Suntreso Government HospitalRead the original story

    Monday Dec 10 | World News Report

    On December 4, 2018, Novo Nordisk, in line with the SDGs and together with the Suntreso Government Hospital, launched a one-stop Diabetes Support Centre to provide comprehensive diabetes care under one roof. This was done to improve access to diabetes care and general awareness about the disease.

    Comment?

  10. Novo Nordisk A/S (NVO) Shares Bought by Janus Henderson Group PLCRead the original story w/Photo

    Monday Dec 10 | AmericanBankingNews.com

    Janus Henderson Group PLC raised its holdings in Novo Nordisk A/S by 2.4% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 208,753 shares of the company's stock after acquiring an additional 4,841 shares during the period.

    Comment?

  11. Capital Bank & Trust Co Has $20.01 Million Holdings in Novo Nordisk A/SRead the original story w/Photo

    Monday Dec 10 | AmericanBankingNews.com

    Capital Bank & Trust Co boosted its stake in shares of Novo Nordisk A/S by 7.8% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 424,561 shares of the company's stock after buying an additional 30,647 shares during the period.

    Comment?

  12. Brokerages Anticipate Novo Nordisk A/S (NVO) to Post $0.61 EPSRead the original story w/Photo

    Sunday Dec 9 | AmericanBankingNews.com

    Equities research analysts expect Novo Nordisk A/S to report earnings of $0.61 per share for the current quarter, Zacks reports. Zero analysts have provided estimates for Novo Nordisk A/S's earnings.

    Comment?

  13. Eli Lilly and Company (LLY): Are Hedge Funds Right About This Stock?Read the original story w/Photo

    Sunday Dec 9 | Insider Monkey

    With the third-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell heading into the fourth quarter. One of these stocks was Eli Lilly and Company .

    Comment?

  14. Credit Suisse AG Cuts Stake in Novo Nordisk A/SRead the original story w/Photo

    Sunday Dec 9 | AmericanBankingNews.com

    Credit Suisse AG decreased its position in shares of Novo Nordisk A/S by 5.6% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 217,014 shares of the company's stock after selling 12,953 shares during the quarter.

    Comment?

  15. Is Altria Group Inc (MO) Going to Burn These Hedge Funds?Read the original story w/Photo

    Sunday Dec 9 | Insider Monkey

    Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages. We only allow registered users to use ad blockers.

    Comment?

  16. Novo Nordisk R&D restructuring signals move to finding innovation externallyRead the original story w/Photo

    Sep 19, 2018 | Chemical & Engineering News

    The drug company is cutting 400 R&D positions and opening 4 new research centers to boost its stem cell therapy work The Danish diabetes drug giant Novo Nordisk is cutting about 400 R&D positions in China and Denmark to make room for four new "biotech-like" research centers that will expand the firm's reach in chronic disease drug development. The company is also establishing a new business development unit in Cambridge, Mass.

    Comment?

  17. Novo Nordisk A/S (NVO) Upgraded by Zacks Investment Research to HoldRead the original story w/Photo

    Friday Dec 7 | Daily Political

    According to Zacks, "Novo Nordisk reported in line earnings but beat sales estimates in third-quarter 2018. However, the company remains optimistic about Ozempic and results for oral semaglutide.

    Comment?

  18. Novo Nordisk pumps $22m into insulin manufacturing siteRead the original story w/Photo

    Thursday Dec 6 | In-PharmaTechnologist.com

    Novo Nordisk will invest $22m in new production lines at its Clayton plant, where the firm conducts formulation, filling, inspection, assembly and packaging of diabetes and obesity medicines. The announcement comes 10 months after announcing a $65m boost in production capacity a at the same site, and follows a $2bn investment across the drugmaker's active pharmaceutical ingredient and production plants in Clayton, US, and MA lA v, Denmark, in 2015 a .

    Comment?

  19. Comment: Danske Bank scandal shows value of holistic approachRead the original story

    Tuesday Dec 4 | Financial Times

    The Nordic corporate governance model is typically regarded as a North Star when it comes to openness, trust and responsibility. Yet, the recent Danske Bank scandal across the Nordics and the Baltics has painted a different picture.

    Comment?

  20. Safety Needles Market Will Hit at a CAGR of 6.9% from 2017 to 2027Read the original story w/Photo

    Monday Dec 3 | SBWire

    ... and Company holds its dominance in the overall market with around 50% share, followed by Medtronic and Novo Nordisk AS. Future Market Insights' recent report profiles Smith Medical and Argon medical Inc. as emerging safety needle manufacturers, ...

    Comment?